ArticleNeurotoxicology2025
Developmental exposure of zebrafish to 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) elicits MPTP-like neurotoxicity.
Article in Neurotoxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) is an endogenous metabolite of the industrial waste trichloroethylene (TCE) and has been implicated as a potent neurotoxicant in TCE-induced neurotoxicity. TaClo has been associated with Parkinson's disease (PD) due to its neurotoxic effects and structural resemblance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Despite the similarities, limited studies have explored the comparative neurotoxicity of MPTP and TaClo within the same experimental models. Zebrafish (Danio rerio) are a powerful high throughput platform for neurotoxicology studies and have been used to evaluate TCE-associated developmental neurotoxicity; however, the role of TaClo in TCE-associated neurotoxicity in the zebrafish model is unknown. To address these gaps, we established an MPTP-induced PD zebrafish larval model and investigated the role of TaClo by comparing its neurotoxic effects with those of MPTP. We exposed embryonic zebrafish to TaClo (5, 50, or 500 ppb) or MPTP (0-17,325 ppb) for 5 consecutive days. We demonstrate that TaClo at 5 ppb elicits 303.2 ppb MPTP-like neurotoxicity in the developmental zebrafish. We determined the lethal concentration 50 of TaClo at the zebrafish larval model at 120 h post-fertilization was 7890 ppb. We show that embryonic zebrafish exposed to TaClo exhibit neurobehavioral impairments, diencephalic dopaminergic neuronal damage, increased cellular apoptosis, astrocytic loss, microgliosis, and altered glutathione peroxidase activity levels. These findings provide important insights into the neurotoxic mechanisms of TaClo and emphasize the utility of developmental zebrafish as a model for studying TaClo-induced neurotoxicity. Our work contributes to environmental contaminants research in neurodegenerative diseases by providing evidence of the potential link between TaClo exposure and PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.